Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-05-24
2010-11-09
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S091100, C435S091200, C435S091210, C536S023500, C436S065000
Reexamination Certificate
active
07829285
ABSTRACT:
Methods and kits are provided for diagnosing, monitoring, or predicting the conditions of pre-eclampsia, fetal chromosomal aneuploidy, and pre-term labor in a pregnant woman, as well as for detecting pregnancy in a woman, by quantitatively measuring in the maternal blood the amount of one or more mRNA species encoding human chorionic gonadotropin β subunit (hCG-β), human placental lactogen (hPL), human corticotropin releasing hormone (hCRH), KiSS-1 metastasis-suppressor (KISS1), tissue factor pathway inhibitor 2 (TPFI2), placenta-specific 1 (PLAC1), or glyceraldehyde-3-phosphate dehydrogenase (GAPDH), and comparing the amount of the mRNA species with a standard control.
REFERENCES:
patent: 5750339 (1998-05-01), Smith
patent: 6258540 (2001-07-01), Lo et al.
patent: 6635452 (2003-10-01), Monforte et al.
patent: 6664056 (2003-12-01), Lo et al.
patent: 2002/0045176 (2002-04-01), Lo et al.
patent: 2460803 (2003-04-01), None
patent: 02/04678 (2002-01-01), None
patent: 02/103352 (2002-12-01), None
patent: 03/095674 (2003-11-01), None
Lee et al. Journal of the National Cancer Institute. 1996. 88: 1731-1737.
Janneau et al. The Journal of clinical Endocrinology & Metabolism. 2002. 87: 5336-5339.
Amicucci, Paola et al.; “Prenatal Diagnosis of Myotonic Dystrophy Using Fetal DNA Obtained from Maternal Plasma”; 2000,Clinical Chemistryvol. 46, No. 2, pp. 301-302.
Braun, Siegmund L. et al.; “Plasma Troponin T and Troponin I after Minimally Invasive Coronary Bypass Surgery”; 2000.Clinical Chemistryvol. 46, No. 2, pp. 279-301.
Chiu, Rossa W.K. et al.; “Prenatal exclusion of β thalassaemia major by examination of material plasma”; 2002,The Lancetvol. 360, pp. 998-1000.
Inder, et al., “The Utility of Plasma CRH as a Predictor of Preterm Delivery;” 2001;The Journal of Clinical Endocrinology & Metabolism; vol. 86; pp. 5706-5710.
Johansen, Marianne et al.; “An Investigation of Methods for Enriching Trophoblast from Maternal Blod”; 1995Prenat. Diagn., vol. 15, pp. 921-931.
Lo, Dennis Y.M. et al.; “Prenatal sex determination from maternal peripheral blood using the polymerase chain reaction”; 1993Hum. Genet., vol. 90, pp. 483-488.
Lo, Dennis Y.M. et al.; “Presence of fetal DNA in maternal plasma and serum”; 1997,The Lancet, vol. 350, pp. 485-487.
Lo, Dennis Y.M. et al.; “Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma”; 1998,The New England Journal of Medicine, vol. 339, No. 24, pp. 1734-1738.
Lo, Dennis Y.M. et al.; “Quantitative Abnormalities of Fetal DNA in Maternal Serum in Preeclampsia”; 1999Clinical Chemistry, vol. 45, No. 2, pp. 184-188.
Lo, Dennis Y.M. et al.; “Increased Fetal DNA Concentrations in the Plasma of Pregnant Women Carrying Fetuses with Trisomy 21”; 1999,Clinical Chemistry, vol. 45, No. 10, pp. 1747-1751.
Lo, Kwok-Wai et al.; “Analysis of Cell-free Epstein-Barr Virus-associated RNA in the Plasma of Patients with Nasopharyngeal Carcinoma”; 1999,Clinical Chemistry, vol. 45, No. 8, pp. 1292-1294.
Ng, Enders K.O. et al.; “mRNA of placental origin is readily detectable in maternal plasma”; 2003,PNAS, vol. 100, No. 8, pp. 4748-4753.
Ng, Enders K.O. et al.; “Presence of Filterable and Nonfilterable mRNA in the Plasma of Cancer Patients and Healthy Individuals”; 2002,Clinical Chemistry, vol. 48, No. 8, pp. 1212-1217.
Ng, Enders K.O. et al.; “The Concentration of Circulating Corticotropin-releasing Hormone mRNA in Maternal Plasma is Increased in Preeclampsia”; 2003,Clinical Chemistry, vol. 49, No. 5, pp. 727-731.
Poon, Leo L.M. et al.; “Presence of Fetal RNA in Maternal Plasma”; 2000,Clinical Chemistry, vol. 46, No. 11, pp. 1832-1833.
Sekizawa, Akihiko et al.; “Cell-free Fetal DNA is Increased in Plasma of Women with Hyperemesis Gravidarum”; 2001,Clinical Chemistry, vol. 47, No. 12, pp. 2164-2165.
Saito, Hiroshi et al.; “Prenatal DNA diagnosis of a single-gene disorder from maternal plasma”; 2000,The Lancet, vol. 356, pp. 1170.
Silva, J.M. et al.; “Detection of epithelial tumour RNA in the plasma of colon cancer patients is associated with advanced stages and circulating tumour cells”; 2002,Gut, vol. 50, pp. 530-534.
Zhong, Xiao Yan et al.; “Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses”; 2000,Prenatal Diagnosis, vol. 20, pp. 795-798.
Zhong, Xiao Yan et al.; “Elevation of both maternal and fetal extracellular circulating deoxyribonucleic acid concentrations in the plasma of pregnant women with preeclampsia”; 2001Am. J. Obstet Gynecol, vol. 184, No. 3, pp. 414-419.
Brizot, Marie L. et al.; “Placental mRNA expression of α and β human chorionic gonadotrophin in early trisomy 18 pregnancies”, 1996,Molecular Human Reproduction, vol. 2, No. 6, pp. 463-465.
Chen, Ellson Y. et al.; “The Human Growth Hormone Locus: Nucleotide Sequence, Biology, and Evolution”; 1989,Genomics, vol. 4, No. 4, pp. 479-497.
Fant, Michael et al.; “PLAC1, a trophoblast-specific gene, is expressed throughout pregnancy in the human placenta and modulated by keratinocyte growth factor”; (abstract) 2002,Molecular Reproduction and Development, vol. 63, No. 4, pp. 430-436.
Poon, Leo L.M. et al.; “Circulating Fetal RNA in Maternal Plasma”; 2001,Antisense Strategies, vol. 945, pp. 207-210.
Yagel, Simcha et al.; “Trophoblasts circulating in matgernal blood as candidates for prenatal genetic evaluation”; 1994,Human Reproduction, vol. 9, No. 6, pp. 1184-1189.
Chiu Wai Kwun Rossa
Lo Yuk-Ming Dennis
Ng Kai On
Tsui Bo Yin
Myers Carla
The Chinese University of Hong Kong
Townsend and Townsend / and Crew LLP
LandOfFree
Circulating mRNA as diagnostic markers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Circulating mRNA as diagnostic markers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Circulating mRNA as diagnostic markers will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4165914